VerdictStats

Securities and Exchange Commission

SEC v. Joseph M. Dupont

Settled$36KFineFiled: June 28, 2023

Joseph M. Dupont, who was then a vice president at Alexion Pharmaceuticals, Inc., allegedly tipped his close friend Shawn P. Cronin to confidential information about the acquisition of Portola Pharmaceuticals Inc. Cronin then allegedly provided the information to Mendoza and Kaplan, and Kaplan, in turn, provided the information to Feldman. Cronin, Mendoza, Kaplan, and Feldman allegedly used this material, nonpublic information to purchased Portola securities prior to the announcement of the acquisition. Kaplan and Feldman allegedly passed information on to other family members and friends, who also profitably traded. According to the SEC, Dupont, Cronin, Kaplan, Feldman and Mendoza violated Sections 10(b) and 14(e) of the Securities Exchange Act of 1934 and Rules 10b-5 and 14e-3 thereunder.

Summary generated from official Securities and Exchange Commission press release

Source: Securities and Exchange Commission Press Release ↗

Parties

Defendants / Respondents
  • Joseph M. Dupont
  • Shawn P. Cronin
  • Stanley Kaplan
  • Paul Feldman
  • Jarett G. Mendoza
  • Alexion Pharmaceuticals, Inc.
  • Portola Pharmaceuticals Inc.

Dates

Filed
June 28, 2023
Resolved
December 22, 2024
Published
January 3, 2025

Case Details

Industry
Pharmaceutical
Penalty Type
Fine